Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gauri Saini

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 7, 2024
Deep Learning-based Segmentation of Computed Tomography Scans Predicts Disease Progression and Mortality in Idiopathic Pulmonary FibrosisMuhunthan Thillai, Justin M Oldham, Alessandro Ruggiero, et al.
BMJ Open Respiratory Research|January 20, 2026
Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS studyFasihul Khan, Iain Stewart, Lucy Howard, et al.
Plos One|August 6, 2016
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary FibrosisAmanda L Tatler, Amanda T Goodwin, Olumide Gbolahan, et al.
BMJ Open Respiratory Research|January 28, 2026
Prospective study of fibrosis in the lung endpoints (PROFILE): characteristics of an incident cohort of patients with idiopathic pulmonary fibrosisToby M Maher, Gisli R Jenkins, Gauri Saini, et al.
ERJ Open Research|December 31, 2025
The clinical utility of elevated monocyte count in patients with fibrotic interstitial lung diseaseBohyung Min, Daniel-Costin Marinescu, Deborah Assayag, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2022
CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE CohortPhilip L Molyneaux, William A Fahy, Adam J Byrne, et al.
Annals of the American Thoracic Society|May 9, 2023
The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE StudyPeter Saunders, Zhe Wu, William A Fahy, et al.
Ebiomedicine|October 20, 2022
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosisMaurizio Chioccioli, Subhadeep Roy, Rachel Newell, et al.
The Lancet. Respiratory Medicine|March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE studyR Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory and Critical Care Medicine|March 7, 2024
Deep Learning-based Segmentation of Computed Tomography Scans Predicts Disease Progression and Mortality in Idiopathic Pulmonary FibrosisMuhunthan Thillai, Justin M Oldham, Alessandro Ruggiero, et al.
BMJ Open Respiratory Research|January 20, 2026
Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS studyFasihul Khan, Iain Stewart, Lucy Howard, et al.
Plos One|August 6, 2016
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary FibrosisAmanda L Tatler, Amanda T Goodwin, Olumide Gbolahan, et al.
BMJ Open Respiratory Research|January 28, 2026
Prospective study of fibrosis in the lung endpoints (PROFILE): characteristics of an incident cohort of patients with idiopathic pulmonary fibrosisToby M Maher, Gisli R Jenkins, Gauri Saini, et al.
ERJ Open Research|December 31, 2025
The clinical utility of elevated monocyte count in patients with fibrotic interstitial lung diseaseBohyung Min, Daniel-Costin Marinescu, Deborah Assayag, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2022
CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE CohortPhilip L Molyneaux, William A Fahy, Adam J Byrne, et al.
Annals of the American Thoracic Society|May 9, 2023
The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE StudyPeter Saunders, Zhe Wu, William A Fahy, et al.
Ebiomedicine|October 20, 2022
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosisMaurizio Chioccioli, Subhadeep Roy, Rachel Newell, et al.
The Lancet. Respiratory Medicine|March 16, 2015
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE studyR Gisli Jenkins, Juliet K Simpson, Gauri Saini, et al.
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
Pageof 4